Chronic Rhinosinusitis Pocket Guide

Building further on the success of the pocket guides for adult and paediatric allergic rhinitis, the European Forum for Research & Education in Allergy & Airway Diseases (EUFOREA) in collaboration with global key opinion leaders in the field of chronic inflammatory airways disease, has developed a CRS pocket guide with a new treatment algorithm with the following aims:

• to expedite access to CRS diagnosis and treatment
• to simplify clinical care pathways of CRS, and
• to facilitate coordinated care amongst the stakeholders involved in CRS care.

The algorithm is based on the EPOS2020 and ICAR-Rhinosinusitis 2021 and is designed for real-life use. Given the clear messages on key diagnostic actions and the simplicity of the CRS algorithm, the EUFOREA pocket guide aims to improve knowledge amongst all stakeholders involved in CRS care and streamline the transition of patients between self-, pharmacy-, GP- and specialist-care, facilitating more coordinated care.

The EUFOREA pocket guide also includes a diagnostic checklist when assessing CRS patients including a list of symptoms suggestive and less suggestive of CRS, questions on suspected comorbid asthma, and instructions on how to use the VAS for CRS. Diagnosing smell dysfunction and nasal congestion or obstruction requires specific diagnostic actions beyond history by health care providers. In addition, a list of suggested indications is provided for referring specific CRS patients to specific colleagues, reflecting the heterogeneity of healthcare providers involved in CRS care. The EUFOREA CRS pocket guide was supported by an unrestricted grant to EUFOREA by Sanofi Genzyme and Regeneron.

The CRS Pocket Guide Paper was recently published in Rhinology Journal featuring the most recent launch CRS Pocket Guide created by EUFOREA. Read the paper here!

English 🇬🇧

Download your copy

Español 🇪🇸

Descarga tu copia

Nederlands 🇳🇱

Download uw exemplaar

Français 🇫🇷

Téléchargez votre copie

Sanofi Regeneron

GSK